DRUiD Announces International Release of Second Patent family.

As part of our continued commitment to scientific innovation and IP protection, we’re pleased to announce the international release of our second patent family: WO2025/068173.

This patent, filed and released through our sister company iDE8, strengthens our portfolio in hydrogel biosensors. While enabling us to focus on developing products in the antimicrobial resistance (AMR) diagnostic space and protects key aspects of our proprietary technology.

By securing global rights, we’re reinforcing our long-term strategy to bring differentiated diagnostic solutions to market—solutions designed to be accurate, scalable, and responsive to global health challenges like AMR.

This release represents another foundational step in protecting the value we’re creating—for patients, providers, and partners alike.